← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2020Last known activity
Aug 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 8 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT06565247Lead sponsorPhase 3Aug 31, 2024
- NCT06565247OfficialPhase 3Aug 31, 2024
- NCT05604729Lead sponsorN/AMar 1, 2023
- NCT05353829Reponsible party - principal investigatorPhase 4Apr 28, 2022
- NCT05353829Lead sponsorPhase 4Apr 28, 2022
- NCT05353829Overall official - principal investigatorPhase 4Apr 28, 2022
- NCT05183178CollaboratorPhase 4Feb 1, 2022
- NCT05164081CollaboratorPhase 3Jan 1, 2022
- NCT05600517CollaboratorN/AAug 25, 2021
- NCT04475601Sponsor investigatorPhase 2Jul 15, 2020
- NCT05309564Lead sponsorN/AMar 1, 2020
Details
- Last known activity
- Aug 31, 2024